Tonix Pharmaceuticals Holding Corp [TNXP] stock prices are up 2.51% to $16.72 at the moment. An important factor to consider is whether the stock is rising or falling in short-term value. The TNXP shares have lost -5.64% over the last week, with a monthly amount drifted -15.13%, and not seem to be holding up well over a long-time horizon.
From an analyst’s perspective:
Previously, ROTH Capital upgraded its rating to Buy on April 18, 2019, and kept the price target unchanged to $4. On August 18, 2017, upgrade upgraded it’s rating to Buy but maintained its price target of $6 on the stock. ROTH Capital downgraded its rating to a Neutral. Oppenheimer reiterated its recommendation of a Outperform and reduced its price target to $10 on February 17, 2016. In a note dated June 12, 2015, Oppenheimer initiated an Outperform rating and provided a target price of $18 on this stock.
The stock price of Tonix Pharmaceuticals Holding Corp [TNXP] has been fluctuating between $6.76 and $130.00 over the past year. Tonix Pharmaceuticals Holding Corp [NASDAQ: TNXP] shares were valued at $16.72 at the most recent close of the market.
Analyzing the TNXP fundamentals
The Tonix Pharmaceuticals Holding Corp [NASDAQ:TNXP] reported sales of 10.30M for trailing twelve months, representing a surge of 16.58%. Gross Profit Margin for this corporation currently stands at 0.29% with Operating Profit Margin at -8.38%, Pretax Profit Margin comes in at -8.28%, and Net Profit Margin reading is -5.41%. To continue investigating profitability, this company’s Return on Assets is posted at -0.28, Equity is -0.38 and Total Capital is -0.49. An extended analysis of the company’s primary financial structure reveals a debt-to-equity ratio of0.0.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 16.13 points at the first support level, and at 15.54 for the second support level. However, for the 1st resistance point, the stock is sitting at 17.78, and for the 2nd resistance point, it is at 18.84.
Ratios To Look Out For
It’s worth pointing out that Tonix Pharmaceuticals Holding Corp [NASDAQ:TNXP]’s Current Ratio is 9.89. On the other hand, the Quick Ratio is 9.62, and the Cash Ratio is 6.58. Considering the valuation of this stock, the price to sales ratio is 19.12, the price to book ratio is 0.74.
Transactions by insiders
Recent insider trading involved Taylor Carolyn E., Director, that happened on Aug 21 ’25 when 418.0 shares were purchased. Director, Treco James completed a deal on Aug 20 ’25 to buy 250.0 shares. Meanwhile, Chief Executive Officer LEDERMAN SETH bought 4000.0 shares on May 15 ’25.
